Connect with Jon Ellis, Philip Coelho, and Joel Bodenmann from Trenchant’s team in Dallas to find out how Trenchant’s platform could shorten CAR-T manufacturing time to 2.5 days. If you’re attending, reach out to us on the Phacilitate app – or through our contact page.  

On Wednesday January 22 from 12:55 – 1:55pm, come listen to the Act for Hope panel discussion where Trenchant’s CEO Jon Ellis will join other cell therapy professionals to discuss emerging digital platforms and processing innovations that could significantly impact cell therapy.